![Shakil Aslam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 91 085 $ as of 2026-08-30
Dr. Shakil Aslam, MD, is a Chief Medical Officer at Talphera, Inc. Dr. Aslam was previously employed as a Vice President-Clinical Development by BioCryst Pharmaceuticals, Inc.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TALPHERA, INC. 0.15% | 2026-05-19 | 76,542 ( 0.15% ) | 91 085 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| TALPHERA, INC. | Chief Tech/Sci/R&D Officer | 2024-09-30 |
| Companies | Position | End |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 2 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Talphera, Inc.
 Talphera, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
